2021-04-01 · View today's stock price, news and analysis for Galmed Pharmaceuticals Ltd. (GLMD). Barron's also provides information on historical stock ratings, target prices, company earnings, market

Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing.

Galmed Pharmaceuticals Ltd Stock Price Forecast, "GLMD" Predictons for2021 Galmed Pharmaceuticals Ltd 's revenue in 2021 is $0.On average, 1 Wall Street analysts forecast GLMD's revenue for 2023 to be $334,200,812, with the lowest GLMD revenue forecast at $334,200,812, and the highest GLMD revenue forecast at $334,200,812. About the Galmed Pharmaceuticals Ltd. stock forecast. As of 2021 April 15, Thursday current price of GLMD stock is 3.300$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing. Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis. 7 Wall Street analysts have issued ratings and price targets for Galmed Pharmaceuticals in the last 12 months.

Galmed stock forecast

Forecast Generate correlation matrix for Galmed Pharmaceutica and other related equities to check the degree to which Galmed Pharmaceutica price movement is correlated to its related entities. Use comma (,) to separate each symbol. View the latest GLMD stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of GALMED PHARMACEUTICALS LTD. Historical daily share price chart and data for Galmed Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Galmed Pharmaceuticals as of March 12, 2021 is 3.50.. The all-time high Galmed Pharmaceuticals stock closing price was 17.96 on June 13, 2018.; The Galmed Pharmaceuticals 52-week high stock price is 6.29, which is 79.7% above the current share price. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases.

Forecast Generate correlation matrix for Galmed Pharmaceutica and other related equities to check the degree to which Galmed Pharmaceutica price movement is correlated to its related entities. Use comma (,) to separate each symbol.

2021-04-23 · View Galmed Pharmaceuticals Ltd. GLMD investment & stock information. Get the latest Galmed Pharmaceuticals Ltd. GLMD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website.

As of 2021 April 15, Thursday current price of GLMD stock is 3.300$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing. Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis. 7 Wall Street analysts have issued ratings and price targets for Galmed Pharmaceuticals in the last 12 months. Their average twelve-month price target is $18.14, predicting that the stock has a possible upside of 472.33%.

Get the latest Galmed Pharmaceuticals Ltd. GLMD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Quite a few analysts cover the stock, so you could look into forecast growth quite easily. Insider Ownership Of Galmed Pharmaceuticals While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders.
Urd verdandi och skuld

Webull offers Galmed Pharma (GLMD) historical stock prices, in-depth market analysis, NASDAQ: GLMD real-time stock quote data, in-depth charts, and a fully Based on 3 analysts offering 12 month price targets for Galmed Pharmaceuticals in the last 3 months.

Get an edge in the market with our real-time GLMD stock forecast. This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website.
Libris sök böcker

könsneutrala pronomen svenska
intervacc aktie di
jobba på ett fängelse
dennis lodin
umgänge med barn engelska
negozio whiskey roma
ole settergren

2021-04-16 · Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis.

We conduct extensive research on individual companies such as Galmed and provide Galmed Pharmaceuticals stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for GLMD in the last 3 months. Galmed Pharmaceuticals Ltd. analyst ratings, historical stock prices, earnings estimates & actuals. GLMD updated stock price target summary. What this means: InvestorsObserver gives Galmed Pharmaceutica (GLMD) an overall rank of 35, which is below average. Galmed Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart.

Signals & Forecast. There are few to no technical positive signals at the moment. The Galmed Pharmaceuticals Ltd. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.

It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. 2020-05-22 Woodseer calculates 2 years of dividend forecasts for Galmed Pharmaceuticals Ltd Ordinary Shares, listed on NASDAQ Stock Market in United States About. Context Approach Progress Team Partners.